NPs Basic Information

Name
Aniquinazoline A
Molecular Formula C27H29N5O4
IUPAC Name*
(1R,12R,14S)-12,14-dimethyl-14-[(2R,4S)-5-oxo-1-phenyl-4-propan-2-ylimidazolidin-2-yl]-13-oxa-2,10,17-triazatetracyclo[10.3.2.02,11.04,9]heptadeca-4,6,8,10-tetraene-3,16-dione
SMILES
CC(C)[C@H]1C(=O)N([C@@H](N1)[C@@]2(C[C@@H]3C(=O)N[C@](O2)(C4=NC5=CC=CC=C5C(=O)N34)C)C)C6=CC=CC=C6
InChI
InChI=1S/C27H29N5O4/c1-15(2)20-23(35)31(16-10-6-5-7-11-16)24(29-20)26(3)14-19-21(33)30-27(4,36-26)25-28-18-13-9-8-12-17(18)22(34)32(19)25/h5-13,15,19-20,24,29H,14H2,1-4H3,(H,30,33)/t19-,20+,24-,26+,27-/m1/s1
InChIKey
YSCMNYAXBOTDDQ-MGYYBZJHSA-N
Synonyms
Aniquinazoline A
CAS NA
PubChem CID 139583876
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Azolidines
        • Subclass: Imidazolidines
          • Direct Parent: Phenylimidazolidines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 487.5 ALogp: 2.6
HBD: 2 HBA: 6
Rotatable Bonds: 3 Lipinski's rule of five: Accepted
Polar Surface Area: 103.0 Aromatic Rings: 7
Heavy Atoms: 36 QED Weighted: 0.588

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.298 MDCK Permeability: 0.00002350
Pgp-inhibitor: 0.996 Pgp-substrate: 0.074
Human Intestinal Absorption (HIA): 0.224 20% Bioavailability (F20%): 0.546
30% Bioavailability (F30%): 0.969

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.048 Plasma Protein Binding (PPB): 71.68%
Volume Distribution (VD): 0.915 Fu: 27.29%

ADMET: Metabolism

CYP1A2-inhibitor: 0.034 CYP1A2-substrate: 0.781
CYP2C19-inhibitor: 0.175 CYP2C19-substrate: 0.824
CYP2C9-inhibitor: 0.757 CYP2C9-substrate: 0.105
CYP2D6-inhibitor: 0.009 CYP2D6-substrate: 0.156
CYP3A4-inhibitor: 0.893 CYP3A4-substrate: 0.93

ADMET: Excretion

Clearance (CL): 7.127 Half-life (T1/2): 0.422

ADMET: Toxicity

hERG Blockers: 0.009 Human Hepatotoxicity (H-HT): 0.964
Drug-inuced Liver Injury (DILI): 0.987 AMES Toxicity: 0.012
Rat Oral Acute Toxicity: 0.081 Maximum Recommended Daily Dose: 0.815
Skin Sensitization: 0.189 Carcinogencity: 0.863
Eye Corrosion: 0.003 Eye Irritation: 0.005
Respiratory Toxicity: 0.6
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003764 0.637 D0B1FE 0.321
ENC003666 0.583 D07VHR 0.305
ENC001948 0.528 D0J6WW 0.290
ENC002409 0.485 D0E4DW 0.289
ENC006010 0.467 D0QV5T 0.288
ENC004348 0.452 D0E3OF 0.287
ENC000977 0.438 D08FTG 0.282
ENC002127 0.437 D0V9WF 0.281
ENC003647 0.436 D09NNH 0.279
ENC004647 0.435 D07NVU 0.278
*Note: the compound similarity was calculated by RDKIT.